COMMUNIQUÉS West-GlobeNewswire

SV Health Investors announces the appointment of Jonathan Behr, PhD as Partner in the Dementia Discovery Fund
02/07/2019
SV Health Investors announces the appointment of Jonathan Behr, PhD as Partner in the Dementia Discovery Fund Former founding managing director of JDRF T1D Fund joins DDF leadership team London, 2 July 2019 - The [...]
Oasmia appoints new CMO
02/07/2019
Nina Heldring, PhD, has today been appointed as acting CMO of Oasmia Pharmaceutical AB. Nina Heldring has 20 years of experience with pre-clinical and clinical medical research from renowned academic institutes and the [...]
Oasmia appoints Scientific Advisory Board
02/07/2019
Oasmia today announces the formation of its Scientific Advisory Board with three key appointments: Professor Rolf Lewensohn, MD, PhD, Hans Grönlund, PhD and Ola Winqvist, MD, PhD. The scientific advisory board will work [...]
Aino Health AB (publ): Aino Health signs cooperation agreement with Aava Occupational Health
02/07/2019
Aino Health and Aava Finland, one of Finland’s largest Occupational Health providers have signed a cooperation agreement where Aava will sell Aino HealthManager and connected implementations services. This cooperation [...]
Nicox signs agreement for NCX 4251 in China with Ocumension Therapeutics for up to €12 million in milestones plus royalties
02/07/2019
Press Release Nicox signs agreement for NCX 4251 in China with Ocumension Therapeutics for up to €12 million in milestones plus royalties Upfront payment of €2 million and potential future milestones of €10 million [...]
Nicox : signature d’un accord sur NCX 4251 avec Ocumension Therapeutics pour la Chine. Paiements d’étape pouvant atteindre 12 millions d’euros plus redevances
02/07/2019
Communiqué de presse Nicox : signature d’un accord sur NCX 4251 avec Ocumension Therapeutics pour la Chine. Paiements d’étape pouvant atteindre 12 millions d’euros plus redevances Paiement initial de 2 millions d’euros [...]
GILEAD ANNOUNCES INTENT TO SUBMIT NEW DRUG APPLICATION FOR FILGOTINIB TO U.S. FOOD AND DRUG ADMINISTRATION THIS YEAR
02/07/2019
Mechelen, Belgium; 2 July 2019; 07.00 CET; regulated information - Gilead Sciences, Inc. (NASDAQ: GILD) today announced that at a recent pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration [...]
Bone Therapeutics SA: Information on the total number of voting rights and shares
02/07/2019
Regulated information Gosselies, Belgium, 2 July 2019, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the leading biotech company focused on the development of innovative cell and biological [...]
Bone Therapeutics SA : Information relative au nombre total de droits de vote et d’actions
02/07/2019
Information réglementée Gosselies, Belgique, le 2 juillet 2019, 07h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de biotechnologie spécialisée dans le développement de thérapies [...]
Cancer Research UK forms partnership with SV Health Investors in life sciences investment fund to accelerate development of cancer medicines
02/07/2019
PRESS RELEASE FOR DISTRIBUTION TO FINANCIAL JOURNALISTS Cancer Research UK forms partnership with SV Health Investors in life sciences investment fund to accelerate development of cancer medicines Strategic partnership [...]
Telix Pharmaceuticals and PI Medical Sign Distribution Agreement for the Netherlands
02/07/2019
MELBOURNE, Australia and RAAMSDONKSVEER, Netherlands, July 02, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the [...]
HTG Presents at the 11th Annual Edition of the Worldwide Innovative Networking (WIN) Symposium
01/07/2019
TUCSON, Ariz., July 01, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced that it presented its [...]
Adaptive Biotechnologies Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
01/07/2019
SEATTLE, July 01, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq:ADPT) (“Adaptive”), a commercial-stage biotechnology company that reads and translates the genetic code of the adaptive immune [...]
Prothena Announces Appointment of Paula K. Cobb to its Board of Directors
01/07/2019
DUBLIN, Ireland, July 01, 2019 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage neuroscience company, announced today the appointment of Paula Cobb to its Board of Directors. “As a [...]
Zosano Pharma Announces Upcoming Presentation at American Headache Society Annual Meeting
01/07/2019
FREMONT, Calif., July 01, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that a poster and e-poster describing Migraine-ACT scores, or [...]
CRISPR Therapeutics Announces Oral Presentation at the 55th Annual Meeting of the European Association for the Study of Diabetes
01/07/2019
ZUG, Switzerland and CAMBRIDGE, Mass., July 01, 2019 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, [...]
Align Technology to Announce Second Quarter 2019 Results on July 24, 2019
01/07/2019
SAN JOSE, Calif., July 01, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) announced today that the Company will report second quarter 2019 financial results on Wednesday, July 24, 2019, after the close [...]
Tauriga Sciences Inc. Experiences Significant Growth and Momentum in its Business During Record Month of June 2019
01/07/2019
New York, NY, July 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, [...]
Corizon Health Secures Additional Term Loan Commitments Under Current Credit Facility
01/07/2019
BRENTWOOD, Tenn., July 01, 2019 (GLOBE NEWSWIRE) -- Corizon Health (“Corizon” or the “Company”), the nation’s leading correctional healthcare company, announced today that it has entered into an amendment and [...]

Pages